Caricamento quotazioni...
Previsioni
Non sono disponibili dati degli analisti per questa azienda.
Notizie Vai al feed delle notizie
American Shared Hospital Services increases revenue in Q2 2026 but misses EPS expectation
American Shared Hospital Services reported Q2 2026 revenue of $8.4 million (+19.2% year‑over‑year), driven by higher patient volumes and growth in direct patient services and proton therapy. Adjusted results showed a loss of $0.07 per share, missing the expected loss of $0.02; however, operating metrics improved and operating cash flow for H1 was $4.4 million, with cash on hand of $6.8 million. Management cites refinancing debt due in 2027 as a priority, secured a 12‑month extension of its credit agreement and obtained $2 million in subordinated financing; the stock reacted slightly positively in premarket trading. » Altro su de.investing.com
American Shared Hospital Services reports Q1 loss, shares fall 4.8%
American Shared Hospital Services reported a Q1 EPS loss of $0.09 on revenue up 15.9% to $7.1 million. The Direct Patient Care Services segment grew 30.2% and gross margin improved to 18.2%, while the operating loss narrowed to $0.9 million. Despite revenue and margin improvements, the stock fell 4.8% in premarket trading to $1.65 as investors focus on ongoing net losses and operational risks. » Altro su de.investing.com
American Shared Hospital Services: CEO Gary Delanois resigns, Craig K. Tagawa named interim CEO
Gary Delanois has resigned as CEO of American Shared Hospital Services for personal reasons; the board appointed president Craig K. Tagawa as interim CEO, and he will retain his role as president. Tagawa’s base salary will be increased from $265,000 to $325,000 effective April 27, 2026, and his target performance bonus for 2026 will rise from 40% to 50% of base salary. The company recently reported Q4 2025 results that missed expectations (EPS -$0.09 vs. forecast $0.04; revenue $7.7 million), which prompted investor uncertainty. » Altro su de.investing.com
Dividendi storici Dividendi
Tutte le metriche sui dividendi Tutte le metricheDati finanziari dell'azienda
| (EUR) | giu 2026 | |
|---|---|---|
| Ricavi | 7,39 Mln | 23,12% |
| Utile lordo | 1,26 Mln | 8,59% |
| Utile netto | -450,37K | 89,58% |
| EBITDA | 336,46K | 72,40% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 8,41 Mln € |
Numero di azioni | 6,63 Mln |
Massimo/minimo a 52 settimane | 2,69 € - 1,08 € |
| Dividendi | No |
Beta | 0,30 |
Rapporto P/E | -5,82 |
Rapporto PEG | -0,18 |
Rapporto P/B | 0,44 |
Rapporto P/S | 0,32 |
Profilo aziendale
American Shared Hospital Services vermietet radiochirurgische und strahlentherapeutische Geräte an Gesundheitsdienstleister. Das Unternehmen bietet Radiochirurgiegeräte für die stereotaktische Radiochirurgie mit dem Gamma Knife an, ein nicht-invasives Verfahren zur Behandlung bösartiger und gutartiger Hirntumore und arteriovenöser Fehlbildungen sowie von Trigeminusneuralgien. Das Unternehmen bietet auch Finanzierungsdienstleistungen für Leksell Gamma Knife-Geräte an. Darüber hinaus bietet das Unternehmen Dienstleistungen im Bereich der Protonenstrahltherapie in Orlando, Florida und Long Beach, Kalifornien, an und unterstützt seine Kunden bei der Planung, Installation, Kostenerstattung und Vermarktung. Zum 31. Dezember 2021 verfügte das Unternehmen über 115 in Betrieb befindliche Gamma Knife-Geräte in den Vereinigten Staaten sowie zwei in Südamerika in Lima, Peru und Guayaquil, Ecuador. Das Unternehmen betreibt außerdem ein PBRT-System. American Shared Hospital Services wurde 1980 gegründet und hat seinen Sitz in San Francisco, Kalifornien.
| Nome | American Shared Hospitalrv. |
| CEO | Craig K. Tagawa |
| Sede centrale | San Francisco,
ca Stati Uniti |
| Sito web | |
| Settore | Sanità |
| Industria | Attrezzature e forniture sanitarie |
| Quotazione in borsa | 03/07/1984 |
| Dipendenti | 83 |
Simboli di borsa
| Borsa | Simbolo |
|---|---|
AMEX | AMS |
Scopri gli asset
Gli azionisti di American Shared Hospitalrv. investono anche nei seguenti asset



